2025 Europe Blood Group Typing Market Revenue Opportunities Report
Description
The 2025 Europe Blood Group Typing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Group Typing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European Blood Group Typing Market are Grifols S.A., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics, and Immucor Inc. (part of Werfen). Grifols leads with innovations like a compact automated bench-top analyzer targeting mid-volume hospitals. Bio-Rad expanded its portfolio in 2025 by acquiring Stilla Technologies to integrate digital PCR for precision transfusion. Ortho Clinical Diagnostics offers broad serology tools with advanced reagent rental models. Immucor, acquired by Werfen, enhances transplant-grade NGS capability, adding molecular genotyping and extended immunohematology services to its offerings.
These companies focus heavily on automation, molecular testing, and integrated workflow solutions to meet demands across European countries such as the UK, Germany, and France. The market in Europe is growing at a CAGR around 7.4% to 10.2%, driven by increased blood donations and transfusions. They also develop partnerships and regional expansions, as seen with Quotient’s presence in several European countries, indicating a competitive landscape evolving via technological advancements and market consolidation.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Group Typing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European Blood Group Typing Market are Grifols S.A., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics, and Immucor Inc. (part of Werfen). Grifols leads with innovations like a compact automated bench-top analyzer targeting mid-volume hospitals. Bio-Rad expanded its portfolio in 2025 by acquiring Stilla Technologies to integrate digital PCR for precision transfusion. Ortho Clinical Diagnostics offers broad serology tools with advanced reagent rental models. Immucor, acquired by Werfen, enhances transplant-grade NGS capability, adding molecular genotyping and extended immunohematology services to its offerings.
These companies focus heavily on automation, molecular testing, and integrated workflow solutions to meet demands across European countries such as the UK, Germany, and France. The market in Europe is growing at a CAGR around 7.4% to 10.2%, driven by increased blood donations and transfusions. They also develop partnerships and regional expansions, as seen with Quotient’s presence in several European countries, indicating a competitive landscape evolving via technological advancements and market consolidation.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
